Clostridial toxin derivatives able to modify peripheral sensory afferent functions
AssigneeSyntaxin Limited
InventorsKeith Alan Foster, Michael John Duggan, Clifford Charles Shone
Life of this patent
Estimating the term…
Loading patent…
AssigneeSyntaxin Limited
InventorsKeith Alan Foster, Michael John Duggan, Clifford Charles Shone
Estimating the term…
This invention describes a novel agent for the targeted control of a mammalian cell activity, in particular the agent is used to control the interaction of particular cell types with their external environment. The agent has applications as a pharmaceutical for the treatment of a variety of disorders. An agent according to the invention comprises three Domains B, T and E linked together in the following manner: Domain B-Domain T-Domain E where Domain B is the Binding Domain which binds the agent to a Binding Site on the cell which undergoes endocytosis to produce an endosome, Domain T is the Translocation Domain which translocates the agent (with or without the Binding Site) from within the endosome across the endosomal membrane into the cytosol of the cell, Domain E is the Effector Domain which inhibits the ability of the Recyclable Membrane Vesicles to transport the Integral Membrane Proteins to the surface of the cell.
A single chain polypeptide fusion protein comprising:
Dependencies are inferred from the claim text.